approved EB-1A
Postdoctoral Researcher
Pharmaceutical Sciences · India · 2025-04-24
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
4 of 3 criteria metScholarly Articles (Met)
The petitioner authored 52 peer-reviewed journal articles in the field of pharmaceutical sciences.
Original Contributions (Met)
The petitioner's research earned 7,116 citations and is used by experts worldwide to develop treatments for chronic kidney disease and cancer.
Judging (Met)
The petitioner performed over 200 peer reviews and served on editorial boards for influential journals.
Memberships (Met)
The petitioner's editorial board service reflects leadership and expertise recognized by the scientific community.
Why This Petition Was Approved
The petition was approved based on the authorship of 52 peer-reviewed journal articles and a massive citation count of 7,116, placing the petitioner in the top 1% of the field. Additionally, the petitioner demonstrated significant peer recognition through over 200 journal reviews and editorial board service. The evidence satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment
Evidence Submitted
- Authorship of 52 peer-reviewed journal articles and 1 accepted article
- 7,116 citations (top 1% of highly cited authors in pharmaceutical sciences)
- Completed more than 200 reviews for prestigious scientific journals
- Editorial board service for influential journals
- Research funding from major international and national agencies
- 21 papers ranked as highly cited in pharmacology and toxicology for their publication years
Similar Cases
Postdoctoral Researcher
Pharmaceuticals · Pakistan
WeGreened EB-1A approved
New York 90 days 2025-02-07
The petition was approved based on meeting at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of others' work, and original scientific contributions of major significance. Specific metrics included 34 journal articles in high-impact venues like Cell Chemical Biology, 1,306 citations with an h-index of 17, and over 25 completed manuscript reviews. Evidence of the commercialization of key compounds further demonstrated the petitioner's extraordinary ability.
Assistant Professor
Pharmaceuticals · India
WeGreened EB-1A rfe approved
Texas 558 days 2025-09-08
The approval was based on a significant publication record of 28 journal articles and a citation count exceeding 360, placing the petitioner in the top 1% of his field. Additionally, his 25 peer reviews and original contributions to antimicrobial and antidiabetic agents satisfied the EB-1A criteria.
Research Scientist
Pharmaceuticals · India
WeGreened EB-1A approved
Texas 142 days 2024-10-21
The petition was approved based on an extensive record of 215 peer-reviewed journal articles, 6 conference papers, 10 preprints, 15 book chapters, 5 books, and 41 patent applications. The petitioner also demonstrated significant influence through over 140 peer reviews for major journals and a high citation impact. These metrics satisfied the EB-1A criteria for scholarly articles, judging, and original contributions of major significance.
Research Scientist
Research and Development · China
WeGreened EB-1A approved
Illinois 6 days 2024-11-05
The petition was approved based on the documentation of 24 peer-reviewed journal articles and a high citation count of 596, placing the applicant in the top 3% of her field. Additionally, her participation in at least 10 journal reviews satisfied the judging criterion. The case was further strengthened by evidence of support from the Department of Energy (DOE) and expert testimony regarding her impact on pharmaceutical development.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-24.
Browse all casesAt a Glance
Outcome approved
Processing 18 days
Criteria Met 4 / 3
Evidence Types 6
EB-1A Case Data
Scraped Case Data
Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist